Literature DB >> 21510763

Analysis of polar metabolites by hydrophilic interaction chromatography--MS/MS.

Wenying Jian1, Yaodong Xu, Richard W Edom, Naidong Weng.   

Abstract

Increasing emphasis has been placed on quantitative characterization of drug metabolites during drug discovery and development. Due to the more polar nature of drug metabolites, quantitative analysis using traditional reversed-phase liquid chromatography tandem mass spectrometry (RPLC-MS/MS) can be quite challenging. As an alternative chromatographic mode, hydrophilic interaction chromatography (HILIC) offers unique advantages for analysis of polar metabolites, providing better retention/separation, higher sensitivity, higher efficiency and potential for ultra-fast analysis to improve throughput. In this article, selected case studies from the authors' own laboratory, and examples from current literature, will be discussed to demonstrate some practical considerations for method development of HILIC-MS/MS assays. The effectiveness of using HILIC-MS/MS for mitigating analytical challenges associated with quantitation of polar metabolites, including phase I and II metabolites of drugs, as well as endogenous metabolites, will be exhibited.

Mesh:

Substances:

Year:  2011        PMID: 21510763     DOI: 10.4155/bio.11.51

Source DB:  PubMed          Journal:  Bioanalysis        ISSN: 1757-6180            Impact factor:   2.681


  2 in total

1.  A high-performance liquid chromatography-tandem mass spectrometry-based targeted metabolomics kidney dysfunction marker panel in human urine.

Authors:  Jacek Klepacki; Jost Klawitter; Jelena Klawitter; Joshua M Thurman; Uwe Christians
Journal:  Clin Chim Acta       Date:  2015-04-11       Impact factor: 3.786

2.  Quantitative hydrophilic interaction chromatography-mass spectrometry analysis of N-acetylneuraminic acid and N-acetylmannosamine in human plasma.

Authors:  Yifan Shi; Xin Xu; Meng Fang; Michael Zhang; Yinghe Li; Brad Gillespie; Selwyn Yorke; Nora Yang; John C McKew; William A Gahl; Marjan Huizing; Nuria Carrillo-Carrasco; Amy Qiu Wang
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2015-07-17       Impact factor: 3.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.